about
Antidepressants and benzodiazepines for panic disorder in adultsAzapirones versus placebo for panic disorder in adultsA new approach to psychiatric drug approval in EuropeAntipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT IntervalINvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocolEffectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trialDoes formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies.Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial.Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis.Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysis.Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare.What is the European Medicines Agency?Antidepressants and benzodiazepines for panic disorder in adults.Implementation of treatment guidelines for specialist mental health care.First-generation antipsychotics and QTc: any role for mediating variables?Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.Regulatory science in Europe: the case of schizophrenia trials.Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.Online Training and Support Programs Designed to Improve Mental Health and Reduce Burden Among Caregivers of People With Dementia: A Systematic Review.Information needs of female Italian breast cancer patients during their first oncological consultation.Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials.Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysisEfficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysisEfficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysisPsychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence
P50
Q24187763-B63F12F8-021E-48D2-B27F-E58FB4B0BFEDQ24193425-E5185972-94D5-4E7B-95E5-E63D9CD843F1Q28534418-F709F742-CDCE-403D-A862-01F37813C24AQ28553078-11CE22CB-6027-443F-92C7-46C9115969CEQ30539583-FD38CC6F-75C5-4CD8-AA7F-61EBAE362D64Q34409921-077A4FCE-4CC5-4150-B83C-CB09C818C70EQ34545159-0CDE7B6B-75F1-4C82-9E5F-F88AEA63191FQ34939218-FAA4F436-17D1-4491-9EBD-8605C8442E37Q36267555-EB1C5B70-4EDF-4020-B054-47965256183BQ36390869-0D603F5D-6CC7-4391-B9B3-F7B551B27A37Q36843320-63DF7730-7E84-46A2-987F-53EBBE832D48Q38026067-AAEF0253-C8EC-46F5-9298-41E3BA4D03A0Q38952014-ADD38464-A369-442B-B8BF-38409017A2BCQ39039245-C1A73009-D34E-475B-BF15-4ECA38CF117AQ39721569-45ECD626-D741-4DFA-9C2E-200192A99302Q40431985-15141F3B-F975-4F85-AD1B-833FDEE46B22Q43852588-BA7A593D-9CFA-4F7F-A22A-5100B000EED3Q47552143-EAC3D54E-1312-4DEA-8121-D064DB9722D6Q47558380-2EC2D9D9-0A73-474D-B968-0301D3FCA2EAQ51042642-A361B7AE-E771-40C1-B2AC-DB264CA13001Q53837434-A4CFE7CE-0B5A-45AE-8016-3FB825A31F74Q59793513-4C086147-6E4B-43E2-BBC8-0B38658772C3Q62079448-9C4AF3E9-07E7-4690-92AD-7B553A863C24Q92055510-A5F2BB67-5340-44FE-B5D7-7AEC53D57B87Q92781256-D6EAE91F-5FB4-4621-8927-A24AFA58D2AF
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5661-5149
@en
name
Irene Bighelli
@ast
Irene Bighelli
@en
Irene Bighelli
@es
Irene Bighelli
@nl
type
label
Irene Bighelli
@ast
Irene Bighelli
@en
Irene Bighelli
@es
Irene Bighelli
@nl
prefLabel
Irene Bighelli
@ast
Irene Bighelli
@en
Irene Bighelli
@es
Irene Bighelli
@nl
P106
P1153
55328078300
P21
P31
P496
0000-0002-5661-5149